| 发明名称 |
INHIBITION OF NEOVASCULARIZATION BY SIMULTANEOUS INHIBITION OF PROSTANOID IP AND EP4 RECEPTORS |
| 摘要 |
There are provided inter alia methods and compounds useful for decreasing neovascularization (e.g., choroidal neovascularization) in a subject in need thereof. |
| 申请公布号 |
US2014275200(A1) |
申请公布日期 |
2014.09.18 |
| 申请号 |
US201414197948 |
申请日期 |
2014.03.05 |
| 申请人 |
ALLERGAN, INC. |
发明人 |
Wang Jenny W.;Woodward David F. |
| 分类号 |
A61K31/403;A61K31/343 |
主分类号 |
A61K31/403 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
1. A method for decreasing neovascularization in a subject in need thereof, comprising administering to said subject an effective amount of an IP receptor antagonist in combination with an effective amount of an EP4 receptor antagonist, thereby decreasing said neovascularization. |
| 地址 |
Irvine CA US |
